Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria

被引:49
作者
Iijima, K [1 ]
Sekine, H [1 ]
Koike, T [1 ]
Imatani, A [1 ]
Ohara, S [1 ]
Shimosegawa, T [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Div Gastroenterol, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
D O I
10.1111/j.1365-2036.2004.01948.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Although profound hypochlorhydria is considered to be an important risk factor for development of gastric cancer, long-term effect of Helicobacter pylori eradication on its reversibility remains uncertain. Aim: To clarify the change in acid secretion after eradication in a long-term follow-up over 5 years in patients with profound hypochlorhydria. Methods: Twenty-three H. pylori-positive patients with hypochlorhydria (<0.6 mmol/10 min) were enrolled prospectively. Assessment of gastrin-stimulated acid output and histologic evaluation of biopsy specimens were performed prior to, and 1, 7 months after eradication. Subsequently, gastric acid secretion was assessed for long-term period over 5 years after eradication in 12 patients. Results: Gastric acid secretion was reversed to normal range in nine of 23 patients (39%) at 7 months after eradication. In the long-term follow-up, gradual and significant recovery in gastric acid secretion was observed up to 2 years post-therapy. However, there was no additional increase during the last 3 years of 5-year follow-up period, leaving the acid secretory levels subnormal in the majority of the patients. Conclusions: This long-term follow-up study suggests that the pathologic process has already progressed to an irreversible stage in the majority of H. pylori-positive patients with marked body atrophy and profound hypochlorhydria.
引用
收藏
页码:1181 / 1188
页数:8
相关论文
共 32 条
[1]
Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625
[2]
The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis [J].
Annibale, B ;
Di Giulio, E ;
Caruana, P ;
Lahner, E ;
Capurso, G ;
Bordi, C ;
Delle Fave, G .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) :1723-1731
[3]
CORREA P, 1990, CANCER RES, V50, P4737
[4]
CORREA P, 1992, CANCER RES, V52, P6735
[5]
Increased prevalence of precancerous changes in relatives of gastric cancer patients:: Critical role of H-pylori [J].
El-Omar, EM ;
Oien, K ;
Murray, LS ;
El-Nujumi, A ;
Wirz, A ;
Gillen, D ;
Williams, C ;
Fullarton, G ;
McColl, KEL .
GASTROENTEROLOGY, 2000, 118 (01) :22-30
[6]
Helicobacter pylori infection and chronic gastric acid hyposecretion [J].
ElOmar, EM ;
Oien, K ;
ElNujumi, A ;
Gillen, D ;
Wirz, A ;
Dahill, S ;
Williams, C ;
Ardill, JES ;
McColl, KEL .
GASTROENTEROLOGY, 1997, 113 (01) :15-24
[7]
Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis [J].
Gutierrez, O ;
Melo, M ;
Segura, AM ;
Angel, A ;
Genta, RM ;
Graham, DY .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (07) :664-668
[8]
Alteration of histological gastritis after cure of Helicobacter pylori infection [J].
Hojo, M ;
Miwa, H ;
Ohkusa, T ;
Ohkura, R ;
Kurosawa, A ;
Sato, N .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (11) :1923-1932
[9]
RADIOIMMUNOASSAY OF SERUM GROUP-I AND GROUP-II PEPSINOGENS IN NORMAL CONTROLS AND PATIENTS WITH VARIOUS DISORDERS [J].
ICHINOSE, M ;
MIKI, K ;
FURIHATA, C ;
KAGEYAMA, T ;
HAYASHI, R ;
NIWA, H ;
OKA, H ;
MATSUSHIMA, T ;
TAKAHASHI, K .
CLINICA CHIMICA ACTA, 1982, 126 (02) :183-191
[10]
Iijima K, 1998, AM J GASTROENTEROL, V93, P2113